Veradigm (MDRX) News Today $5.00 0.00 (0.00%) As of 12:39 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Veradigm (NASDAQ:MDRX) Sets New 1-Year Low - What's Next?Veradigm (NASDAQ:MDRX) Sets New 12-Month Low - Here's What HappenedMarch 1 at 6:11 PM | marketbeat.comVeradigm (NASDAQ:MDRX) Now Covered by Analysts at StockNews.comStockNews.com initiated coverage on Veradigm in a report on Saturday. They set a "hold" rating for the company.March 1 at 2:07 AM | marketbeat.comVeradigm Becomes First EHR Media Platform to Achieve POCMA CertificationFebruary 27, 2025 | businesswire.comVeradigm (NASDAQ:MDRX) Shares Gap Up - Time to Buy?Veradigm (NASDAQ:MDRX) Shares Gap Up - Should You Buy?February 26, 2025 | marketbeat.comVeradigm (NASDAQ:MDRX) Shares Up 4.9% - Still a Buy?Veradigm (NASDAQ:MDRX) Stock Price Up 4.9% - Should You Buy?February 24, 2025 | marketbeat.comVeradigm (NASDAQ:MDRX) Shares Gap Up - Should You Buy?Veradigm (NASDAQ:MDRX) Shares Gap Up - Time to Buy?February 21, 2025 | marketbeat.comStockNews.com Begins Coverage on Veradigm (NASDAQ:MDRX)StockNews.com initiated coverage on shares of Veradigm in a research report on Friday. They set a "hold" rating for the company.February 21, 2025 | marketbeat.comVeradigm Announces Board Expansion and ChangesFebruary 20, 2025 | finance.yahoo.comVeradigm Expands Board with Strategic AppointmentsFebruary 20, 2025 | tipranks.comVeradigm agrees to board refreshment in settlement with Kent Lake CapitalFebruary 20, 2025 | reuters.comVeradigm (NASDAQ:MDRX) Shares Gap Down - What's Next?Veradigm (NASDAQ:MDRX) Shares Gap Down - What's Next?February 19, 2025 | marketbeat.comVeradigm Introduces Cardiometabolic Clinical Registry Datasets to Enhance the Next Generation of Real-World ResearchFebruary 18, 2025 | businesswire.comVeradigm (NASDAQ:MDRX) Coverage Initiated at StockNews.comStockNews.com started coverage on shares of Veradigm in a research note on Thursday. They set a "hold" rating on the stock.February 13, 2025 | marketbeat.comVeradigm (NASDAQ:MDRX) Shares Gap Up - Still a Buy?Veradigm (NASDAQ:MDRX) Shares Gap Up - Still a Buy?February 11, 2025 | marketbeat.comVeradigm (NASDAQ:MDRX) Shares Down 4.7% - Should You Sell?Veradigm (NASDAQ:MDRX) Trading Down 4.7% - Time to Sell?February 10, 2025 | marketbeat.comVeradigm (NASDAQ:MDRX) Shares Gap Up - Here's What HappenedVeradigm (NASDAQ:MDRX) Shares Gap Up - Here's What HappenedFebruary 5, 2025 | marketbeat.comVeradigm (NASDAQ:MDRX) Now Covered by StockNews.comStockNews.com assumed coverage on shares of Veradigm in a research report on Wednesday. They issued a "hold" rating for the company.February 5, 2025 | marketbeat.comBlack Book Ranks Veradigm EHR the #1 Ambulatory EHR for Family Practice and Primary Care PracticesFebruary 3, 2025 | finance.yahoo.comVeradigm (NASDAQ:MDRX) Shares Gap Down - Here's WhyVeradigm (NASDAQ:MDRX) Shares Gap Down - Should You Sell?February 3, 2025 | marketbeat.comVeradigm stock tumbles after strategic review ends without agreementFebruary 1, 2025 | msn.comVeradigm ends exploration of strategic alternatives without dealJanuary 31, 2025 | markets.businessinsider.comTD Cowen Keeps Their Buy Rating on Veradigm (MDRX)January 31, 2025 | markets.businessinsider.comVeradigm stock tumbles as strategic review ends without a dealJanuary 31, 2025 | msn.comVeradigm (NASDAQ:MDRX) Hits New 1-Year Low - What's Next?Veradigm (NASDAQ:MDRX) Reaches New 52-Week Low - What's Next?January 31, 2025 | marketbeat.comStephens Boosts Veradigm (NASDAQ:MDRX) Price Target to $13.00Stephens upped their price target on Veradigm from $7.00 to $13.00 and gave the stock an "equal weight" rating in a research note on Friday.January 31, 2025 | marketbeat.comVeradigm Announces the Resignation of Board Director Beth Altman Due to Health ReasonsJanuary 31, 2025 | finance.yahoo.comVeradigm Ends Business Review Process on Lack of Final BidsJanuary 31, 2025 | marketwatch.comVeradigm ends strategic review after no firm bidsJanuary 31, 2025 | msn.comVeradigm Concludes Exploration of Strategic Alternatives and Announces Operational ReviewJanuary 30, 2025 | businesswire.comVeradigm (NASDAQ:MDRX) Stock Price Down 5% - What's Next?Veradigm (NASDAQ:MDRX) Trading Down 5% - What's Next?January 29, 2025 | marketbeat.comVeradigm (NASDAQ:MDRX) Trading 19.7% Higher - Still a Buy?Veradigm (NASDAQ:MDRX) Trading Up 19.7% - Time to Buy?January 28, 2025 | marketbeat.comVeradigm (NASDAQ:MDRX) Shares Gap Up - What's Next?Veradigm (NASDAQ:MDRX) Shares Gap Up - Still a Buy?January 27, 2025 | marketbeat.comVeradigm (NASDAQ:MDRX) Sees Large Volume Increase - Still a Buy?Veradigm (NASDAQ:MDRX) Sees Large Volume Increase - Here's WhyJanuary 23, 2025 | marketbeat.comVeradigm (NASDAQ:MDRX) Shares Gap Down - Here's What HappenedVeradigm (NASDAQ:MDRX) Shares Gap Down - Here's What HappenedJanuary 22, 2025 | marketbeat.comVeradigm Adds Social Determinants of Health and Mortality Data to EHR Database to Allow Deeper Insights into the Patient JourneyJanuary 13, 2025 | finance.yahoo.comVeradigm (NASDAQ:MDRX) Trading 8.8% Higher - Should You Buy?Veradigm (NASDAQ:MDRX) Shares Up 8.8% - Time to Buy?January 3, 2025 | marketbeat.comVeradigm (NASDAQ:MDRX) Stock Price Down 6.5% - What's Next?Veradigm (NASDAQ:MDRX) Stock Price Down 6.5% - Here's WhyJanuary 2, 2025 | marketbeat.comVeradigm interim CFO gets another term extensionJanuary 2, 2025 | seekingalpha.comVeradigm (NASDAQ:MDRX) Coverage Initiated by Analysts at StockNews.comStockNews.com assumed coverage on shares of Veradigm in a research note on Friday. They issued a "hold" rating for the company.December 27, 2024 | marketbeat.comVeradigm (NASDAQ:MDRX) Stock Price Down 2.7% - Time to Sell?Veradigm (NASDAQ:MDRX) Trading Down 2.7% - Time to Sell?December 26, 2024 | marketbeat.comVeradigm (NASDAQ:MDRX) Trading 5.3% Higher - Still a Buy?Veradigm (NASDAQ:MDRX) Stock Price Up 5.3% - Here's What HappenedDecember 18, 2024 | marketbeat.comVeradigm (NASDAQ:MDRX) Shares Gap Down - Time to Sell?Veradigm (NASDAQ:MDRX) Shares Gap Down - Time to Sell?December 16, 2024 | marketbeat.comVeradigm (NASDAQ:MDRX) Stock Price Down 4.5% - Should You Sell?Veradigm (NASDAQ:MDRX) Shares Down 4.5% - Here's WhyDecember 13, 2024 | marketbeat.comVeradigm (NASDAQ:MDRX) Earns Hold Rating from Analysts at StockNews.comStockNews.com started coverage on shares of Veradigm in a research report on Wednesday. They issued a "hold" rating on the stock.December 11, 2024 | marketbeat.comGlancy Prongay & Murray LLP Announces Investigation of Veradigm Inc. (MDRX)December 10, 2024 | tmcnet.comVeradigm Launches an Ambient Scribe Advancement to Ease the Healthcare Administrative BurdenNovember 22, 2024 | finance.yahoo.comVeradigm in srategic collaboration with EHR decision platform InsiteflowNovember 20, 2024 | markets.businessinsider.comVeradigm Advancing Point of Care Engagement Through Payer-Provider CollaborationNovember 19, 2024 | businesswire.comVeradigm (MDRX) Earnings Dates & ReportsNovember 13, 2024 | investing.comVeradigm And The 2025 M&A BoomNovember 13, 2024 | seekingalpha.com Get Veradigm News Delivered to You Automatically Sign up to receive the latest news and ratings for MDRX and its competitors with MarketBeat's FREE daily newsletter. Email Address MDRX Media Mentions By Week MDRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDRX News Sentiment▼0.250.76▲Average Business Services News Sentiment MDRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDRX Articles This Week▼42▲MDRX Articles Average Week Get Veradigm News Delivered to You Automatically Sign up to receive the latest news and ratings for MDRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Omnicell News Today HealthStream News Today NetScout Systems News Today Verint Systems News Today Ribbon Communications News Today ECARX News Today OneSpan News Today Simulations Plus News Today Digimarc News Today Unisys News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MDRX) was last updated on 3/4/2025 by MarketBeat.com Staff From Our Partners77 Hedge Funds Are Betting On This Off-Radar MineralWith surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fa...The Tomorrow Investor | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veradigm Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veradigm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
